Growing Demand for Interventional Oncology Devices to Boost the Growth of Interventional Oncology Devices Market

North America currently holds the largest market share in terms of revenue generation. North America interventional oncology devices market was valuedat$965.90million in 2018. High prevalence of cancer, growing geriatric population, and high reimbursement rates are the prominent factors propelling the growth of the North America interventional oncology devices market. However, the market for interventional oncology devices market in Asia-Pacific is anticipated to witness the highest growth rate during the forecast period. The massive demand for interventional oncology devices, large geriatric population base, demand for minimally invasive and non-invasive surgical procedures, and high prevalence rates of cancer, is the leading contributor to the growth of the Asia-Pacific interventional oncology devices market.

The interventional oncology devices market in economies such as Japan, China, India, and South Korea, among others possesses significant scope for the expansion of operations by key players of the interventional oncology industry. The countries mentioned above witnessed high incidence of cancer, and the rise of the massive demand for interventional oncology devices is bolstered by the large proportion of the geriatric population of the respective economies. However, the lack of favourable reimbursement policies is hampering the growth of the interventional oncology devices market.

The strategies followed by various prominent companies, to sustain in the competition and expand their market share, have been varying from product launch to acquisitions. The market witnessed two business expansions, fourteen product launches, seven significant acquisitions and mergers, three collaborations, joint ventures, and partnerships, and two awards and recognitions. The key contributors to the global interventional oncology devices market have been launching innovative products and have been involved in mergers and acquisitions to sustain in the intensely competitive market. In correlation with the high prevalence of cancer, North America is currently the largest shareholder, in terms of revenue generation.

Comments

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @ https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023. The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...

BIS Research ( Business Intelligence and Strategy Research)

Search This Blog